NCT06532526

Brief Summary

The main aim of this randomized controlled clinical trial is to evaluate the efficacy of a bioactive glass desensitizer in reducing tooth sensitivity associated with in-office vital tooth bleaching. In addition, this study aims to compare the effectiveness of the bioactive glass desensitizer with that of a fluoride gel and a gel without desensitizing agent with regard to incidence, intensity, and duration of tooth sensitivity and, finally, to investigate how these agents affect tooth-shade following in-office bleaching. The hypothesis of the study is: There will be no difference in the effect of a bio-active glass desensitizer on tooth sensitivity associated with vital in-office tooth bleaching compared to a fluoride gel and the bio-active glass desensitizer has no effect on the bleaching efficacy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

July 25, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

August 1, 2024

Status Verified

July 1, 2024

Enrollment Period

7 months

First QC Date

July 25, 2024

Last Update Submit

July 29, 2024

Conditions

Keywords

SensitivityBio-active desensitizerin-office bleaching

Outcome Measures

Primary Outcomes (1)

  • Tooth sensitivity associated with vital in-office tooth bleaching

    Tooth sensitivity associated with vital in-office tooth bleaching using the the five-point Numeric Rating Scale (NRS): 0: No sensitivity 1. Mild sensitivity, 2. Moderate sensitivity 3. Considerable sensitivity 4. Severe sensitivity Also, sensitivity will be evaluated using the visual analog scale of pain (VAS). The VAS is a horizontal line containing 10 numbers from 0 to 10; zero indicates no pain and 10 indicates the worst pain. Participants will be asked to mark the number that indicated their level of pain. The participants will be asked to record the stimulus that caused sensitivity, including hot, cold, or other. The duration of pain, whether seconds, minutes, or hours, will be recorded for the 14-day follow-up period. For descriptive analysis purposes, the intensity results will be categorized according to the following scale: 0 = none, 1-3 = mild, 4-6 = moderate, and 7-10 = severe.

    Assess sensitivity during the bleaching, 1 hour after bleaching, 1 day, 2 days, 7 days and 14 days after bleaching.

Secondary Outcomes (1)

  • Efficacy of bleaching

    Evaluate teeth shade subjectively and objectively after the removal of isolation and after 14 days of bleaching.

Study Arms (3)

First group

ACTIVE COMPARATOR

Predicat Bioactive desensitizer

Other: Predicta® Bioactive Desensitizer (PBD, PARKELL, EDGEWOOD, NY, USA)

Second group

ACTIVE COMPARATOR

Gel with 1.23% sodium fluoride

Other: Gel with 1.23% sodium fluoride (EAZIGEL, VERICOM CO., LTD. SOUTH KOREA)

Third group

PLACEBO COMPARATOR

Placebo gel

Other: Placebo gel without any active ingredients.

Interventions

A bioactive desensitizer gel that applied on teeth to reduce tooth sensitivity associated with dental bleaching.

First group

Fluoride gel that applied on the teeth to reduce tooth sensitivity

Second group

Water-based glycerin gel is used as the Placebo gel without active ingredients

Third group

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • At least eight maxillary anterior teeth present.
  • Age between 18 and 30 years Smokers
  • The selected teeth has a mean shade of C2 or darker (Vitapan Classical, Vita-Zahnfabrik, Sa¨ckingen, Germany)
  • Good general and oral health (no visible plaque or gingivitis)
  • No restorations or carious lesions on the buccal surfaces of the anterior teeth to be whitened
  • No history of tooth sensitivity
  • No use of a desensitizing agent or desensitizing toothpaste in the past six months

You may not qualify if:

  • Active caries and/or periodontal diseases (gingivitis and recession) or wasting diseases
  • Smokers
  • Pregnant/lactating women
  • Patients who have bleached their teeth previously
  • No schedule availability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jordan University of Science and Technology

Irbid, P.O.Box 3030, Jordan

RECRUITING

Related Publications (1)

  • Maghaireh GA, Alzraikat H, Altarazi MY. Effects of a bioactive desensitizing material on in-office bleaching-induced tooth sensitivity: A randomized double-blind controlled trial. J Dent. 2026 Jan 1;166:106326. doi: 10.1016/j.jdent.2025.106326. Online ahead of print.

MeSH Terms

Conditions

Tooth DiscolorationHypersensitivity

Interventions

GelsSodium Fluoride

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

ColloidsComplex MixturesDosage FormsPharmaceutical PreparationsFluoridesHydrofluoric AcidFluorine CompoundsInorganic ChemicalsSodium CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Ghada A Maghaireh

    Jordan University of Science and Technology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ghada A Maghaireh

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants as well as the evaluators will be informed about the nature and objectives of the study; however, they will not be informed what desensitizing material they would receive.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study will be a double blinded (Patient and evaluator) randomized clinical trial with a sample size of 51, 17 participants for each group (n=17).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

July 25, 2024

First Posted

August 1, 2024

Study Start

July 1, 2024

Primary Completion

January 30, 2025

Study Completion

April 1, 2025

Last Updated

August 1, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations